Displaying items 13-24 of 107
» View ky3.com items only
< Previous
1
2
3
4
5
6
7
8
9
Next >
-
PRESS DIGEST - Wall Street Journal - May 10
ReutersMay 10 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. * The federal deficit is shrinking faster than expected due to surging tax revenue and bailout...Tags: The Wall Street Journal
-
REUTERS SUMMIT-Faster drug approvals a tonic for pharma industry
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) By Ben Hirschler NEW YORK, May 8 (Reuters) - A pickup in new drug approvals, the promise of faster regulatory decisions and more targeted medicines have...Tags: Breast Cancer, Rheumatoid Arthritis, Novartis AG, Diabetes, Biogen Idec Incorporated
-
RESEARCH: A hard life at the bench
Tribune staff reporterPresident Bush's decision on whether the federal government will fund embryonic stem cell research could open the door to a new generation of budding scientists or perhaps send many of them packing in search of a more favorable research climate or more...Tags: National Institutes of Health, Biology, Science, Social Issues, Diseases and Illnesses
-
REUTERS SUMMIT-Drug industry CEOs plotting more carve-outs
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) * New generation of CEOs more open to restructuring * Established drug products in focus at Pfizer, GSK, Sanofi * Bankers see divestments helping to unlock...Tags: HIV, Companies and Corporations, Bain Capital, LLC, Restructuring and Recapitalization, Corporate Officers
-
FDA approves J&J sedation drug device
ReutersMay 3 (Reuters) - U.S. regulators have approved Johnson & Johnson's Sedasys system to sedate patients during colonoscopies without the need for a physician to monitor delivery of the injectable sedating agent, the company said on Friday. The device...Tags: Food and Drug Administration, Colonoscopy, Propofol (drug)
-
Dow Jones y S&P 500 marcan récord en Wall St, impulsados por datos de empleo
ReutersPor Ryan Vlastelica NUEVA YORK (Reuters) - El promedio industrial Dow Jones y el índice S&P 500 cerraron en máximos históricos el viernes en la bolsa de Nueva York, con alzas en torno al 1 por ciento en los principales referenciales del mercado tras...Tags: NASDAQ, Chevron Corportion, Financial Markets, LinkedIn Corp., Nasdaq Composite
-
India regulators pull J&J plant license on baby powder concerns
Reuters* Officials say sterilization process not compliant * J&J says will appeal decision * Latest in long string of J&J quality problems May 3 (Reuters) - Health officials in India have revoked Johnson & Johnson's license to make cosmetics at a plant...Tags: Food and Drug Administration, Consumers, Medical Procedures and Tests, Tylenol (drug), India
-
UIC launches $10M seed fund to advance startups
Tribune reporterThe University of Illinois at Chicago is launching a $10 million fund to help inventions advance from the research stage toward potential commercial opportunities, becoming the latest academic institution in the area to channel increased resources...Tags: Startups, HIV, National Institutes of Health, Invention and Innovation, Northwestern University
-
FACTBOX-Valeant's deal-machine stays on overdrive mode
ReutersApril 29 (Reuters) - Canada's Valeant Pharmaceuticals International Inc continued to focus on acquisitions under Chief Executive Michael Pearson, a former McKinsey & Co director even though talks on a merger with U.S.-based Actavis Inc stalled last week....Tags: Brazil, Medicis Pharmaceutical Corporation, Drugs and Medicines, Teva Pharmaceutical Industries Limited, Cephalon Incorporated
-
Boehringer anti-clotting pill gains blockbuster status
ReutersINGELHEIM, Germany, April 24 (Reuters) - Boehringer Ingelheim said its anti-blood-clotting drug Pradaxa reached blockbuster status in 2012, helping the world's largest unlisted drugmaker to an 11.5 percent rise in sales for last year. Sales of the pill,...Tags: Xarelto (drug), Pradaxa (drug), Germany, Diabetes, Drugs and Medicines
-
RPT-ANALYSIS-Ahead of reform, medical care slowdown hits US companies
Reuters(Repeats story to additional subscribers) By Bill Berkrot NEW YORK, April 22 (Reuters) - As the clock ticks down to the start of a U.S. healthcare overhaul, companies from device makers to hospital chains have been surprised to see Americans make even...Tags: Healthcare Industry, Instrument Engineering, Crime, Law and Justice, Medical Procedures and Tests, Health Care Reform (2009)
-
ANALYSIS-Ahead of reform, medical care slowdown hits US companies
ReutersBy Bill Berkrot NEW YORK, April 22 (Reuters) - As the clock ticks down to the start of a U.S. healthcare overhaul, companies from device makers to hospital chains have been surprised to see Americans make even fewer trips to the doctor's office. Use...Tags: Healthcare Industry, Instrument Engineering, Crime, Law and Justice, Medical Procedures and Tests, Health Care Reform (2009)
May 9, 2013
|Story| Reuters
May 8, 2013
|Story| Reuters
Jul 29, 2001
|Story| Chicago Tribune
May 7, 2013
|Story| Reuters
May 3, 2013
|Story| Reuters
May 3, 2013
|Story| Reuters
May 3, 2013
|Story| Reuters
Apr 26, 2013
|Story| Chicago Tribune
Apr 29, 2013
|Story| Reuters
Apr 24, 2013
|Story| Reuters
Apr 22, 2013
|Story| Reuters
Apr 21, 2013
|Story| Reuters
Original site for Johnson & Johnson Inc. topic gallery.